Table 1.
Baseline clinical and biochemical characteristics
| N | Mean | SD | |
|---|---|---|---|
| Age | 69 | 65 | 13 |
| Dialysis vintage (months) | 69 | 63 | 92 |
| Kt/V urea | 68 | 1.54 | 0.38 |
| White blood cells (thousands/μl) | 69 | 5.6 | 1.6 |
| Hemoglobin (g/dl) | 69 | 11.5 | 1.3 |
| 25-OH-vitamin D (ng/ml) | 64 | 16 | 10 |
| Total proteins (g/dl) | 69 | 6.6 | 0.5 |
| Albumin (g/dl) | 69 | 3.76 | 0.59 |
| Calcium (mg/dl) | 69 | 9.1 | 0.5 |
| Phosphate (mg/dl) | 69 | 4.8 | 1.5 |
| Cholesterol (mg/dl) | 69 | 154 | 36 |
| Triglycerides (mg/dl) | 69 | 127 | 75 |
| CRP (mg/dl) | 69 | 8.6 | 14.2 |
| Parathormone (pg/ml)a | 69 | 235 | 123–414 |
| EPO dose (U/week) | 62 of 69 (90%) | 5199 | 7724 |
| Calcium-based P binders (mg/day) | 20 of 69 (29%) | 1329 | 859 |
| Sevelamer (mg/day) | 33 of 69 (48%) | 4388 | 2601 |
| Lanthanum (mg/day) | 23 of 69 (33%) | 2641 | 764 |
| Magnesium-based P binders (mg/day) | 8 of 69 (12%) | 822 | 397 |
EPO, erythropoietin; P, phosphate.
a
Median and interquartile range shown.